News to Use
Faculty and Staff News
News to Use
New IUSM campus names debut July 1
On July 1 many IU School of Medicine regional campuses will no longer be identified formally by their host campus. During the most recent legislative session, the Indiana General Assembly passed a bill changing the names of seven of the nine IUSM campuses.
Original legislation required that the regional centers be located on various campuses of IU or other universities and their names reflected that affiliation. Some of the new academic buildings constructed to house the regional programs were built off site from those campuses, including the new Evansville building which will be located in downtown Evansville, not on the University of Southern Indiana campus.
"Senate Bill 123 simply updated the status of the IUSM regional campuses," said Jeffrey Linder, IU associate vice president for public affairs and government relations. "As we were correcting the Evansville status, we thought it was also necessary to update the state statutes as they pertain to all our campuses to make certain that state law reflected the reality of where those campuses are actually located."
The new names of the regional campuses are:
- Indiana University School of Medicine-Evansville (formerly -Evansville at the University of Southern Indiana)
- Indiana University School of Medicine-Fort Wayne (formerly -Fort Wayne at Indiana University-Purdue University Fort Wayne)
- Indiana University School of Medicine-Muncie (formerly -Muncie at Ball State University)
- Indiana University School of Medicine-Northwest-Gary (formerly -Northwest at Indiana University Northwest)
- Indiana University School of Medicine-South Bend (formerly -South Bend at the University of Notre Dame)
- Indiana University School of Medicine-Terre Haute (formerly -Terre Haute at Indiana State University)
- Indiana University School of Medicine-West Lafayette (formerly -Lafayette at Purdue University)
The names of the Medical Sciences Program at Indiana University Bloomington and the Indiana University School of Medicine-Indianapolis at Indiana University-Purdue University Indianapolis are unchanged.The names of the campuses are under the domain of the Indiana General Assembly, which created the regional campus system in the late 1960s to answer a need for more medical school graduates in Indiana. Under the direction of IUSM Dean Glenn W. Irwin Jr., M.D., the statewide medical education system, known as the "Indiana Plan" was approved. In 1968, pilot programs were established at West Lafayette and South Bend. In 1971, the nine Statewide Medical Education Centers were opened and students could complete their first two years of medical school at Bloomington, Evansville, Fort Wayne, Gary, Muncie, South Bend, Terre Haute, West Lafayette and of course, Indianapolis.
The journey to re-accreditation continuesAs the IU School of Medicine's preparation for re-accreditation by the Liaison Committee on Medical Education continues, the Road to Accreditation is the source for related resources and information. Committee descriptions and membership lists have just been added. Have a question about the re-accreditation pursuit? Submit it to firstname.lastname@example.org.
"Pocket Square Project" featured in Indianapolis Star articleA project to raise funds for counseling and education services for children with HIV in Kenya and spearheaded by an IU School of Medicine physician, was highlighted recently in the Indianapolis Star. Rachel Vreeman, M.D., associate professor of pediatrics at IUSM, director of research for the IU Center for Global Health and co-director of research and pediatric HIV care for the AMPATH program in Kenya, is co-founder of The Pocket Square Project -- an initiative that raises funds through the sale of pocket squares made from colorful African kitenge cloth. Read the article.
Paydar selected as new IUPUI chancellor
On June 19, the IU Board of Trustees confirmed the selection of Nasser H. Paydar, executive vice chancellor and chief academic officer at IUPUI, as the campus' next chancellor.
Paydar, whose appointment begins Aug. 16, succeeds Charles R. Bantz, who retires as chancellor after 12 years in the position.
"Nasser is an ideal candidate to build on the considerable momentum the IUPUI campus has generated over the past 12 years under Chancellor Bantz," said IU President Michael A. McRobbie. "Nasser is an outstanding academic and an energetic, able leader who has a deep understanding of IU’s goals and mission. As executive vice chancellor for the past three years, Nasser has shown a tremendous ability to bring disparate groups together to create a strategic vision for the IUPUI campus that will allow for a seamless transition."
Paydar, who will become IUPUI’s fifth chancellor, has been an IU faculty member for nearly 30 years and has held various administrative and executive leadership positions since he joined IUPUI in 1985 as an assistant professor of mechanical engineering. He has been executive vice chancellor since 2012; he served as vice chancellor and dean of Indiana University-Purdue University Columbus from 2004 to 2007 and as chancellor at IU East in Richmond from 2007 to 2012.
IUPUI is at a special time in its history and development, Paydar said, citing the growth of the campus, accolades it’s received for innovative academic and community engagement programs, and its profile as a leading urban campus.
"As chancellor, I look forward to building on the momentum we have established at IUPUI and developing and implementing IUPUI’s long-term vision, built on the success of our students, to fulfill the campus’s commitment to Indiana and beyond," he said.
Previous IUPUI chancellors were Maynard Hine (dentistry), Glenn Irwin (medicine), Gerald Bepko (law) and Charles Bantz (communication studies/liberal arts).
Nagy appointed CMO of IU Health adult AHC
Ryan D. Nagy, M.D., assistant professor of clinical anesthesia, has been appointed to the newly created position of chief medical officer for the IU Health adult academic health center. The new role is a consolidation of the IU Health Methodist and University hospitals' CMO roles.
The new CMO role parallels the chief nursing officer position consolidation now held by Linda Chase, Ph.D., R.N., and enables consistent execution of clinical strategies throughout the adult AHC enterprise, along with partnering with the Riley Hospital for Children at IU Health leadership team to achieve benchmark performance levels on quality, safety and service priorities.
Dr. Nagy's areas of focus will include:
- Building more creative and productive relationships in the physician community and with IU School of Medicine and other related schools (allied health, public health, business), as well as with potential partners in innovation, education, research and community health.
- Supporting and developing approaches to improve physician alignment.
- Leading the development of clinical and other aspects of the future AHC.
- Partnering with Linda Chase and the quality leadership team to further develop a culture of safety and lead quality initiatives.
- Collaborating with Jonathan Gottlieb, M.D., executive vice president and chief medical officer for IU Health, on systemwide clinical initiatives.
Stage play to raise awareness of Alzheimer's is July 16; reserve free tickets
The Indiana Alzheimer Disease Center at the IU School of Medicine and USAgainstAlzheimer’s are sponsoring the production of "Forget Me Not" at 1 p.m. Thursday, July 16, at the Indiana Repertory Theatre in downtown Indianapolis. Tickets to the play are free.
"Forget Me Not" is an award-winning play that aims to raise awareness about Alzheimer’s disease. A touching play about love and hope, "Forget Me Not" takes the audience into the life of a family facing this medical challenge and shows its impact not just on the immediate family, but its effect on friends, marriage and those in the community as well.A question-and-answer session will be presented during the production to answer questions about diagnosis, research and treatment for Alzheimer’s disease and related dementias. Preview on You-Tube. Reserve free tickets online or call 202-349-3803 for more information.
Annual Neonatology Symposium is Aug. 7
Plan to attend "New Approaches to Neonatal Liver and GI Disease" -- the Fourth Annual Neonatology Symposium presented by The Makenna Van Laeken Pediatric Liver Disease Endowment on Friday, Aug. 7, on the IUPUI campus.
Peter F. Whitington, M.D., Sally Burnett Searle Professor of Pediatrics and Transplantation, Northwestern University Feinberg School of Medicine, is the keynote speaker. Course topics include:
- Neonatal Nissen/G-tube surgery
- Total parenteral nutrition and neonatal liver disease
- Necrotizing enterocolitis
- Neonatal hyperbilirubinemia, rare causes and management
- Neonatal liver disease
Public Health Award reception to honor Janice Farlow
A reception honoring Janice Farlow, who will receive the U.S. Public Health Service's 2015 Excellence in Public Health Award, will begin at 2 p.m. Thursday, July 2, in the VanNuys Medical Science Building atrium.
Farlow has been active in medical service-learning activities and served as the medical chair of the IU Student Outreach Clinic, a free student-run clinic on Indianapolis' Near Eastside. She has served as a student representative on the IU Board of Trustees since 2013 and is the past president of the Medical Student Council. Farlow is completing a dual M.D./Ph.D. and is scheduled to graduate in 2017.The U.S. Public Health Service, a part of the U.S. Surgeon General's Office, awards this honor to U.S. medical students who are involved in public health issues in their community and are committed to increasing awareness of the Public Health Service’s mission to protect, promote and advance the health and safety of American citizens.
Indiana CTSI awards funding to encourage budding scientists
The Indiana Clinical and Translational Sciences Institute recently announced the 2015-16 recipients for Young Investigator Training Awards, TL1 Postdoctoral and Predoctoral Training Awards. The awards, funded by CTSI -- and partially funded by the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award, Neuroscience Strategic Research Initiative and institutional support-- are focused on improving young scientists at the participating universities.
For this period, CTSI was able to fund four postdoctoral awards (two renewals and two new awards), 17 predoctoral awards (nine renewals and eight new awards), and nine Young Investigator Awards (five renewals and four new awards).
The 2015 Young Investigator new awardees:
- Jill Fodstad, Ph.D., assistant professor of psychiatry, IU School of Medicine, is developing a parent–training program to decrease early self-injury in infants and toddlers with developmental disabilities.
- Craig Lammert, M.D., assistant professor of medicine, IU School of Medicine Digestive and Liver Diseases, is studying autoimmune liver diseases and contributing exposures.
- Troy Markel, M.D., assistant professor of pediatric surgery, IU School of Medicine, is studying the effects of human bone marrow as an alternate therapy for intestinal ischemia.
- Tamika Zapolski, Ph.D., assistant professor of psychology, IUPUI, is planning to modify and pilot test a behavior therapy intervention to reduce risk-taking behaviors in adolescents.
The 2015 Young Investigator renewal awardees:
- Laurie Littlepage, Ph.D., assistant professor of cancer research, University of Notre Dame, is researching how to identify cells that become resistant to chemotherapy and how to develop therapies that lead to a more favorable prognosis.
- Jason Mackey, M.D., assistant professor of neurology, IU School of Medicine, is studying imaging characteristics that are predictive of patient outcomes when addressing a common type of stroke.
- Eric Orman, M.D., assistant professor of medicine (gastroenterology & hepatology), IU School of Medicine, is testing ways to optimize care for hospitalized patient with liver cirrhosis.
- Ukamaka Oruche, Ph.D., R.N., assistant professor, IU School of Nursing, is developing a family management efficacy intervention for African-American families of adolescents with disruptive behavior disorders.
- Dennis Watson, Ph.D., assistant professor, Department of Health Policy and Management, IU Fairbanks School of Public Health, is studying housing as a clinical intervention for individuals with co-occurring mental health and substance abuse disorders.
The 2015 TL1 Postdoctoral awardees:
- Irina Castellanos, Ph.D., Department of Speech, Hearing and Sensory Communication, IU School of Medicine, is documenting the components of visual conceptual thinking in children with cochlear implants to determine the effects on academic achievement and social-emotional development (renewal).
- Andrea Frump, Ph.D., Department of Pulmonology, IU School of Medicine, is studying molecular and translational approaches to right ventricular failure (new).
- Patrick Quinn, Ph.D., Department of Psychological and Brain Sciences, IU, Bloomington, is analyzing large databases to study the causes and consequences of opioid and other substance abuse (new).
- Holly Weiss-Bilka, Ph.D., Department of Developmental Bone Biology, University of Notre Dame, is investigating cranial bone formation, so that clinical procedures can be designed to work in concert with the body’s natural biological growth processes (renewal).
The 2015-16 Predoctoral Awardees are:
Indiana University School of Medicine
Arianne Aslamy, Department of Cellular & Integrative Physiology, is investigating beta cell specific drug targets to promote insulin release and beta cell survival (new).
Joey Contreras, Department of Medical Neuroscience, is examining early neurodegenerative changes as they relate to Alzheimer’s disease (new).
Cassandra (Palmer) Gohn, Department of Cellular & Integrative Physiology is focusing on diabetes in pregnancy (new).
David McIlwain, Department of Pharmacology & Toxicology, is researching cell survival and taxane-resistance in prostate cancer (renewal).
Jillian Noblet, Department of Cellular & Integrative Physiology, is investigating perivascular adipose and obesity-induced coronary disease (renewal).
Indiana University-Purdue University Indianapolis
Kyle McGregor, School of Social Work, is examining the capacity of teens with chronic illnesses to consent to clinical research (renewal).
Sarah Ohlemacher, Department of Biology, is investigating human stem cell-derived retinal ganglion cells and glaucoma (new).
Indiana University Bloomington
Brandi Emerick, Department of Psychological & Brain Sciences is studying the effect of cannabis use on visual perception, attention and neural synchrony (renewal).
Nicholas Pulliam, Department of Molecular & Cellular Biochemistry, is working on therapies for ovarian cancer (new).
Justine Arrington, Department of Chemistry/Biochemistry, is conducting research on the identification of Alzheimer’s disease biomarkers (renewal).
Brittani Bungart, Department of Biomedical Engineering, is researching the diagnosis of prostate cancer (new).
Joselyn Cruz, Department of Basic Medical Sciences, is exploring therapeutic approaches for brain tumors (new).
Jessica Page, Department of Basic Medical Sciences, is investigating potassium channel blockers in relationship to restoration of impulse conduction in animal spinal cord injury (renewal).
Joyatee Sarker, Weldon School of Biomedical Engineering, is exploring the mathematical modeling of hematopoietic stem cell transplants (renewal).
Richard Sayer, Department of Nutrition Science, is studying the effects of diet and exercise on the neural response to visual food stimuli (renewal).
Evan Usler, Department of Speech, Language, and Hearing Sciences, is analyzing the neural correlates mediating language processing in children with persisting stuttering, children who have recovered from stuttering, and fluent controls (renewal).
University of Notre DameTimothy Riley, Department of Chemistry & Biochemistry, is engineering cell receptor immunotherapy associated with hepatocellular carcinoma (new).
MicroRNA may provide therapy against pancreatic cancer
IU cancer researchers found that a particular microRNA may be a potent therapeutic agent against pancreatic cancer. The research was published June 22 in the journal Scientific Reports.
Led by Janaiah Kota, Ph.D., assistant professor of medical and molecular genetics at the IU School of Medicine and a researcher at the IU Melvin and Bren Simon Cancer Center, the researchers found that restoring missing microRNA-29 (miR-29) in pancreatic cancer stromal cells reduced the viability and growth of the cancerous cells.
A thick fibrotic shell around the cancer cells is known as “stroma,” which protects the pancreatic cancer cells from anticancer drugs such as chemotherapy.
“We found that the loss of miR-29 is a common phenomenon of pancreatic cancer stromal cells, and that by restoring it, the stromal accumulation and cancer growth was reduced,” Dr. Kota said. “The use of miR-29 as a therapeutic agent may be more effective in targeting reactive stroma, as a single miRNA regulates the expression of several genes associated with disease mechanisms.”
“In healthy cells and tissues, a single miRNA controls the expression of hundreds of genes, and any alterations in their normal expression leads to abnormal overexpression of bad genes that are favorable for the growth of cancer cells and are harmful to normal cells,” Dr. Kota explained.
Dr. Kota and his colleagues were studying the role of small non-coding RNAs called miRNAs in molecular mechanisms associated with pancreatic cancer stroma to evaluate their use for therapeutic intervention in pancreatic cancer. They found that there is loss of miR-29 in stroma of the pancreatic tumors compared to the healthy pancreas. The researchers expected its expression in stromal cells would restore normal function of stromal cells and reduce the abundance of fibrotic stromal proteins. However, they were surprised that when they co-cultured miR-29 overexpressing stromal cells with cancer cells, it also reduced the viability and growth of cancer cells for unknown factors.
They are currently performing additional studies to understand the molecular mechanisms associated with the effect of miR-29 overexpression in stromal cells on cancer cells as well as in preclinical animal models.
“This is a novel approach that has the potential to overcome the problems associated with current anti-stromal drugs and that could lead to improved therapeutic strategies, enhanced drug delivery to the tumor bed, and, in the future, improved patient survival,” said Murray Korc, M.D., the Myles Brand Professor of Cancer Research at the IU School of Medicine and a researcher at the IU Simon Cancer Center. Dr. Korc is also director of the Pancreatic Cancer Signature Center.
The need for new therapies for pancreatic cancer patients is great as only 7 percent of people with the disease survive more than 5 years after diagnosis. According to the National Cancer Institute, there will be an estimated 48,960 new cases of pancreatic cancer and 40,560 deaths from the disease in 2015.
The research was supported by the Elsa U. Pardee Foundation and the Pancreatic Cancer Signature Center.Other IU collaborators included Romil Saxena, M.D.; Grzegorz Nalepa, M.D., Ph.D.; Jesse Gore, Ph.D.; Zhangsheng Yu, Ph.D.; Zahi Abdul-Sater; Ravi Alluri Ph.D.; Smiti Sahu; Sarah Nabinger; and first author Jason Kwon, as well as Zachary Vega of Wabash College.
Population health program improves well-being of older adults, caregivers
The Aging Brain Care Medical Home, a novel population health management program implemented in the homes of older adults, achieves significant health improvement for individuals with depression and also substantial stress reduction in family caregivers of dementia patients, according to a new study by investigators from the Regenstrief Institute, IU Center for Aging Research and Eskenazi Health.
The researchers report at least a 50 percent reduction in symptoms in two-thirds of patients with moderately severe depressive symptoms such as feeling hopeless, feeling bad about oneself or having trouble concentrating. They also found a 50 percent reduction in stress symptoms in half of caregivers of patients with dementia.
"Depression and dementia, which typically impact other medical conditions, are difficult for primary care doctors to treat during their limited time with patients," said Regenstrief Institute investigator and IU Center for Aging Research scientist Michael LaMantia, M.D., MPH, who led the study. "The Aging Brain Care Medical Home program may be an attractive option in response to some of the challenges posed by our nation's rapidly aging population and the anticipated lack of geriatricians and primary doctors to care for them."Care coordinator assistants go to patients’ homes, develop relationships with them, evaluate the safety of the home environment, focus on the needs of both patients and caregivers, and offer support to deal with the many consequences of a depression or dementia diagnosis. We send our teams out to patients’ homes with the tools they will need to work with older adults. Our team members are our front line who alert us to problems the medical team wouldn't otherwise know about."
Faculty and Staff News
Wilkes leaving IUSM to serve as UVA medical school dean
David Wilkes, M.D., executive associate dean for research affairs, will leave the IU School of Medicine next month. After more than 22 years as an accomplished physician-researcher and administrative leader, he has accepted the position of dean of the University of Virginia School of Medicine.
"The selection of David for this leadership position at the UVA School of Medicine is a reflection of his talent and expertise," said Jay L. Hess, M.D., dean of the IU School of Medicine and vice president for university clinical affairs.
"David has been the driving force behind a number of achievements including the Transforming Research Initiative, which has better positioned the School of Medicine for advancing team-based science and helped increase research funding more than 20 percent during the past year. Under his leadership, the school attained one of our best rankings in NIH funding in 2014," Dr. Hess said.
A pulmonologist and researcher with expertise in transplantation and idiopathic pulmonary fibrosis, Dr. Wilkes served as director of the Center for Immunobiology and founded the Indianapolis startup company ImmuneWorks. As executive associate dean for research affairs, he brought new resources to the school through the Strategic Research Initiative and the Physician Science Initiative. He worked to promote research success and mentoring through the creation of the Peer Review and Mentoring Committees and the Independent Investigator Incubator."I've had the pleasure of working and collaborating with many exceptionally talented and dedicated people during two decades at IUSM, during which time the school strengthened its science and built new research resources -- a process to which I was honored to contribute," Dr. Wilkes said. "I'm looking forward to new challenges at another great institution."
Volunteers sought for new Faculty Assembly
A new advisory body to the Faculty Steering Committee is forming to improve communication between the dean's office and the faculty. The new advisory body is the recommendation of the Faculty Steering Committee, following a request from Dean Jay Hess to develop a more efficient and effective approach to communication with faculty.
Each department is asked to select one faculty member to represent its interests. Faculty members interested in serving on the newly created advisory body to the Faculty Steering Committee should contact their department chairs as soon as possible. The deadline for chairs to submit the name of their department's Faculty Assembly representative is Friday, July 10.
Faculty Assembly representatives will be non-voting members of the Faculty Steering Committee, but will participate in the monthly meetings and ad hoc committee work. Faculty Assembly members will be responsible for communicating Faculty Steering Committee initiatives and updates from the dean to their department colleagues. They will also be charged with bringing faculty issues back to the committee. The monthly Faculty Steering Committee meetings will include dedicated time for Faculty Assembly representatives to present ideas, concerns and initiatives from department faculty.
The initial Faculty Assembly representative appointments will be for either two or three years so that term expirations will be staggered. Following the initial appointments, representatives will cycle off the assembly every two years. Faculty are eligible to serve more than one term.
Faculty Assembly members should be strong communicators; be willing to share the concerns and suggestions of fellow faculty; and be prepared to advocate for department peers.
The Faculty Steering Committee meets on the third Thursday of each month from noon to 1:30 p.m. Faculty Steering Committee-Faculty Assembly members will be invited to attend the August meeting when the committee resumes meeting for the 2015-2016 academic year.Department chairs should submit their Faculty Assembly appointment to Melody Darnall at email@example.com no later than Friday, July 10.
Search underway for new executive associate dean for research affairs
IU School of Medicine Dean Jay Hess, M.D., Ph.D, vice president for university clinical affairs, invites applications and nominations for the position of executive associate dean for research affairs.
The IUSM research mission has recently experienced rapid growth with total external funding up by 20 percent this year and a rising National Institutes of Health ranking among public medical schools at 16th in 2014. The executive associate dean for research affairs will provide vision and strategic leadership for the full depth and breadth of the school’s research mission as it continues to expand its extramural funding base and accelerate its national reputation as a leader in research.
The candidate filling this position must be a collaborative leader and coalition-builder to advance research across the enterprise, including the IU Health statewide system, Eskenazi Health and the Richard L. Roudebush Veterans Administration Medical Center. The EAD will cultivate relationships and promote an appropriate culture of entrepreneurism by partnering with other university units; external academic, industry and community partners; and various funding, philanthropic, regulatory and accrediting bodies. The EAD will foster resources, mentoring and research-related faculty development opportunities to propel the research mission forward, and will chart a course for the future of IUSM research that maximizes multidisciplinary thematic research areas, grows basic and translational research, expands clinical trials and facilitates novel public-private partnerships.
Among the many areas of responsibility, the EAD for research affairs has oversight of the graduate division, Laboratory Animal Resource Center, the Office of Research Administration, research space and multiple school-level research centers and institutes. In addition, the EAD provides leadership and direction for several key programs such as the Strategic Research Initiative, Physician-Scientist Initiative, Industry Collaborations Portal, Independent Investigator Incubator, Peer Review and Mentoring Committees and Project Development Teams.Applications for this exciting leadership opportunity will be accepted until July 9.
Fellowship opportunity focuses on women's and diversity affairs
The Office of Faculty Affairs and Professional Development announces a fellowship opportunity designed to advance the collaboration between programs for the advancement of women and diversity affairs while providing an opportunity for professional growth and development.
The fellow will:
- Complete a one-year project designed to maximize the synergy between diversity affairs and programs for the advancement of women.
- Co-chair the Women's Advisory Council.
- Serve as liaison to the Association of American Medical Colleges Group on Women in Medicine and Science.
- Provide leadership for existing programs for the advancement of women.
The fellowship will include .10 FTE for a period of one year with potential for renewal and financial support to attend one national scholarly meeting or conference (up to $4,000). This position will report to Mary Dankoski, Ph.D., executive associate dean for faculty affairs and professional development. The fellow will work closely with the leadership teams in OFAPD and diversity affairs for mentoring, feedback and project guidance. Shared administrative assistance will also be provided.Candidates interested in this fellowship opportunity should apply online. If interested in applying, submit one PDF containing a curriculum vitae and a letter of interest that describes the project or proposal you envision, how this fellowship will contribute to your professional development and what you hope to gain from the experience. Priority application deadline is July 15.
Indiana CTSI to sponsor inaugural hemorrhagic stroke meeting
The Indiana Clinical and Translational Sciences Institute will sponsor the inaugural Indiana Hemorrhagic Stroke Meeting on Tuesday, June 30, at the JW Marriott in Indianapolis.
The meeting will bring together neurosurgeons, neurologists, stroke specialists, nurses, stroke care support teams and chief medical officers to learn about new opportunities for treating intracerebral hemorrhage, also known as hemorrhagic stroke, the most deadly form of stroke. Recent clinical evidence shows that early surgical intervention of hemorrhagic stroke using new access technology can mitigate brain injury and result in a faster and more complete recovery.
Speakers include Mitesh Shah, M.D., president of Goodman Campbell Brain and Spine in Indianapolis; Ronald Young, M.D., neurosurgeon, and Jeffrey Hilburn, M.D., neurologist, both of St. Vincent Hospital Indianapolis; and Jonathan Ratcliff, M.D., assistant professor of emergency medicine and neurology at Emory University School of Medicine, Atlanta.
A hands-on lab showcasing novel technologies used to address ICH will include a live demonstration of a new approach for intracerebral clot evacuation using access technology called the NICO BrainPath.Meeting details and agenda are available. For more information, call Brenda Hudson, CTSI Indiana Hemorrhagic Stroke Meeting coordinator, at 317-278-0913. Online registration is available.
Reflections submissions due June 30
Do you have the soul of a poet? How about the eye of an artist? Perhaps you are the teller of tales? If so, your talent may be a perfect addition to Reflections, the IUSM student-led creative arts therapy journal.
Each year, students, faculty, administrators and staff are asked to make submissions of poetry, essays, stories, photos or artwork for possible publication in the booklet, which is distributed to incoming medical students at the White Coat Ceremony and also published online. Each edition has a theme related to the practice of medicine, healing, learning, helping and other altruistic qualities.
This year's theme is "ME in Medicine - Self in the Sprint" and contributors are asked to share thoughts about self, including but not limited to how they lost, retained or found themselves in medicine. The "sprint," said co-editors Carla Arellano and Stefani Tica, relates to how medical training and practice can seem similar to running a race.Submissions to Reflections will be accepted through June 30.
Applications for Molecular Therapeutics Program due July 1
The Molecular Therapeutics Program, part of the Indiana Clinical and Translational Sciences Institute, seeks applications for a competitive program that will provide funds and essential consultation to support the early stage development of therapeutics.
This opportunity is provided in concert with the newly established Indiana Drug Discovery Alliance, a clearinghouse for drug discovery and development resources at the Indiana-CTSI member institutions of Indiana University, Purdue University and the University of Notre Dame.
The Molecular Therapeutics Program will support new collaborations and/or the use of core facilities that enable the translation of fundamental research related to drug discovery. A detailed budget is not required at this time. Supported projects will develop a budget of up to $15,000 in consultation with the IDDA.Application deadline is 5 p.m. July 1. Complete guidelines and application forms are available for download from the Indiana CTSI grants portal. Applicants must log in using their institutional username and password. Application instructions are under Indiana Drug Discovery Alliance - 2015.07. For more information, contact Padma Portonovo at firstname.lastname@example.org.
Williams honored by professional meetings organizationRokeena Williams, activity coordinator in the Division of Continuing Medical Education, received "Member of the Year" honors at the 22nd annual IMPRESS Awards for the Indiana Chapter of Meeting Professionals International on June 18. MPI is a professional organization for the global meetings industry.
Dankoski named MedEdPORTAL associate editorMary Dankoski, Ph.D., IUSM executive associate dean for faculty affairs and professional development, has been chosen as the associate editor for the Faculty Affairs Collection in MedEdPORTAL, an Association of American Medical Colleges publication that promotes educational scholarship and collaboration by facilitating the open exchange of peer-reviewed health education teaching and assessment resources.
Four IUSM scientists named Showalter Scholars
Four scientists have been named Showalter Scholars by the IU School of Medicine, the third class in the program created to recognize and reward successful young researchers at the school.
The recipients are:
- Nickolay Brustovetsky, Ph.D., associate professor of pharmacology and toxicology
- X. Charlie Dong, Ph.D., associate professor of biochemistry and molecular biology
- Shaun Grannis, M.D., associate professor of family medicine
- Molly Duman Scheel, Ph.D., associate professor of medical and molecular genetics at IU School of Medicine-South Bend
The program, funded in part by Ralph W. and Grace M. Showalter Research Trust Fund, was created to support faculty whose scientific expertise and productivity have resulted in significant contributions to the IU School of Medicine and the greater research community.
Showalter Scholars receive $25,000 per year for three years, with the first year funded by the Showalter Trust, the second year by their academic department and the third year by the school. An additional set of Showalter Scholars is selected each year.
"We are grateful for the commitment to IU School of Medicine scientists and their research made by the Showalter Trust, and we're pleased to be able to support the trust's investment in this excellent group of researchers," said David S. Wilkes, M.D., executive associate dean for research affairs at the IU School of Medicine.Showalter Scholars are limited to full-time IU School of Medicine faculty who are either an associate professor or have held the rank of professor for no more than one year.